The company in question is, AstraZeneca PLC (NYSE:AZN) currently with a stock price of 30.78 (0.84% today). The market cap for AstraZeneca PLC is 77179.84, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for AstraZeneca PLC is 34.41. Currently AstraZeneca PLC is trading with a P/E of 26.43, and a forward P/E of 13.57. Average volume for AstraZeneca PLC is 4857.98 and so far today it is 5324836.
Performance in the last year for AstraZeneca PLC has been -4.97%. For EPS growth, AstraZeneca PLC has seen a growth of 128.90%, and is looking to grow in the next year to -4.50%. More long term stats show that EPS growth has been -16.70% over the last five years and could be -1.00% for the next five years. AstraZeneca PLC has seen sales growth quarter over quarter at 1.00%, with EPS growth quarter over quarter at 17.50%. The 20-day simple moving average is 5.22%, with the 200-day simple moving average coming to 2.20%.
Since the IPO date for AstraZeneca PLC on the 5/17/1993, AstraZeneca PLC has seen performance year to date to be -7.16%. With AstraZeneca PLC trading at 30.78, the dividend yield is 6.22%, and the EPS is 1.16.
So could AstraZeneca PLC, be undervalued? Well as said before P/E is 26.43. The PEG is *TBA, P/S is 3.12 and the P/B is at 5.24. The P/cash is 18.83, with P/free cash flow at *TBA.
AstraZeneca PLC ability to deal with debt shows that the current ratio is 0.8, and the quick ratio is 0.7. This is with long term debt/equity at 0.96, and total debt/equity at 1.11.
In terms of margins, AstraZeneca PLC has a gross margin of 82.80%, an operating margin of 17.00% and a profit margin of 11.80%.Payout ratio for AstraZeneca PLC is 121.20%. Return on assets come to 5.00% with return on investment coming to 11.50%.
Insider ownership for AstraZeneca PLC, is at 0.50% and institutional ownership comes to 10.80%. Outstanding shares are at 2528. While shares float is 2503.73. The float short is currently 1.01%, and short ratio is 5.2.